Navigation Links
Roche Receives FDA Approval for cobas p 630 Pre-analytical Solution for Automated Molecular Testing Platform
Date:3/30/2012

BAS® instruments and analyzers. One AMPLILINK data station will connect one cobas p 630 Instrument to up to three COBAS® AmpliPrep instruments and three analyzers (combination of COBAS® TaqMan® and COBAS® TaqMan® 48 analyzers), helping to maximize throughput capabilities and optimize laboratory efficiencies. The software's bi-directional connectivity gives labs the capability of having patient orders sent from their Laboratory Information System (LIS) to the cobas p 630 Instrument, tracking the patient sample from the time the order is entered through the LIS to reporting of the patient result.

About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

All trademarks used or mentioned in this release are protected by law.

For further information please contact:
Molecular Diagnostics Communications at 888-545-2443


'/>"/>
SOURCE Roche
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rochester Medical Reports Fiscal 2012 First Quarter Results
2. Roches Sequence Capture Technology Used to Identify SMPX Mutations Underlying Human Hereditary Hearing Loss
3. Rochester Medical Announces First Quarter 2012 Earnings Conference Call, Wednesday, January 25, 2012
4. Rochester Medical Director Schnobrich to Retire
5. Roche Acquires Verum Diagnostica GmbH as Part of Plan to Develop Comprehensive Coagulation Testing Portfolio for Diagnostic Laboratories
6. Roche, ChanTest Collaborate for Preclinical Cardiac Safety Testing of Drug Compounds Using iCell Cardiomyocytes and xCELLigence RTCA Cardio Instrument
7. Roche Diagnostics, Cedars-Sinai Medical Center Enter Strategic Alliance for Center to Operate as a Roche Molecular Center of Excellence
8. Rochester Medical Reports Fourth Quarter and Fiscal Year End Results
9. Roche Receives FDA Approval for Acute Hepatitis B Test
10. Rochester Medical Announces Fourth Quarter 2011 Earnings Conference Call Thursday, November 3, 2011
11. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets  has ... Pipeline Insight 2014" report to their offering. ... is one of the largest segments of pharmaceuticals industry. The ... while the available therapies were unable to meet the market ... market for CNS disorder, especially over the past two decades. ...
(Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
(Date:8/29/2014)... Pa. , Aug. 29, 2014  Unilife Corporation ... UNS) announced today that it intends to release its ... year ended June 30, 2014 after market trading ends ... has scheduled a conference call for 4:30 p.m. U.S. ... 2014 at 6:30 a.m. AEST), to review the Company,s financial ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
... Biosciences announced,today, the initiation of a Phase 2 ... management of acute infectious,mononucleosis. Currently, there are no ... or any other disease caused by,the Epstein-Barr virus ... of anti-viral activity,including inhibition of viral replication of ...
... Dec. 6 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... ), has begun a Phase 1 clinical trial of ... R343,for the treatment of allergic asthma. R343 is the ... terms of the companies, 2005 collaboration agreement, Rigel,will receive ...
Cached Medicine Technology:Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 3
(Date:8/30/2014)... (PRWEB) August 30, 2014 Final ... release of the TransGhost plugin from Pixel Film Studios. ... gives users the ability to tell their scary story ... Pixel Film Studios. “Users will make their audience scream ... plugin.” , With TransGhost users can awaken evil spirits ...
(Date:8/30/2014)... 30, 2014 Zensah®, the leader in compression ... Leg Sleeve . The camo sleeves are the first released ... collection. The camo line includes classic colors like army green ... , Known as tibial stress syndrome, shin splints cause dull ... leg. Swollen and irritated muscles, stress fractures, or over pronation ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Barton Associates, ... practitioner locum tenens company , announces a new ... 1, 2014. Barton Associates is headquartered in Peabody, MA, ... Keene, NH; and Jupiter, FL. , Barton ... the increasing demand for healthcare providers. The United States ...
(Date:8/30/2014)... The KSF (Kung Fu Sanshou Federation) ... on November 8th, 2014 at the Mobile Civic Center ... introduced many notorious and notable fighters for some top ... UFC. , Among these KSF along with the ... armed with the virtues of true indomitable Shaolin spirit, ...
(Date:8/30/2014)... What challenges exist in recruiting top talent for ... and considerations? Sports Conflict Institute ’s Joshua ... Woody Wommack, Southeast Football Recruiting Analyst of Rivals.com/Yahoo! Sports ... Notably, Wommack spoke on what the recruiting process ... are coming as a result of the O’Bannon trial, ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 2Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 3Health News:Camo Compression Leg Sleeves Provide Shin Splint Relief for Runners 2Health News:Barton Associates Announces New Office Location in Austin, TX 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 3Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 4Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 3
... ... TUMSRacing.com, PITTSBURGH, July 9 TUMS, one ... nationwide search for,one lucky fan to serve as the Grand Marshal of ... Va. on October,19, 2008., (Photo: http://www.newscom.com/cgi-bin/prnh/20080709/AQW525 ), "TUMS, and ...
... CCA Industries,Inc. (Amex: CAW ) announced today the ... weight loss and cholesterol lowering dietary supplement,to be available ... non drug dietary supplement, formulated with,green tea and a ... be targeted to the approximately 23 million overweight,adults in ...
... researcher Dr. Daniel Von Hoff, a member ... provides an in-depth look at "The Complete ... that creates rapid accrual rates, substantial economies ... investigators and patients, and improved therapeutic benefits. ...
... Health meets global needs for the increasingly complex healthcare ... ... Cohn & Wolfe has announced the,formation of GCI Health, a ... healthcare industry. GCI Health, which,will be led by Jill Dosik as ...
... July 9 The HealthCentral,Network, Inc. ... medical and peer-to-peer resource,committed to helping and ... and nutrition, along with offering a place ... writers, University of Pennsylvania clinical instruction,Dr. Jeffrey ...
... is part of uKarma,s vertical integration strategy and ... launch complementary health and wellness brands, LOS ... UKMA), a lifestyle multimedia and consumer products company,focused ... the,first Xflowsion studio will open in Southern California ...
Cached Medicine News:Health News:TUMS Announces Nationwide Search for Grand Marshal at TUMS QuikPak 500 2Health News:CCA Industries, Inc. Introduces a New Diet Aid Supplement 2Health News:Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit 2Health News:Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit 3Health News:Cohn & Wolfe Launches GCI Health, One of the World's Largest Healthcare Public Relations Firms 2Health News:Responding to Increased Incidence of Obesity and Associated Health Issues, The HealthCentral Network Launches Site to Support those Struggling with Weight 2Health News:uKarma to Open First Xflowsion Fitness Studio With Celebrity Trainer Eric Paskel 2
Portal accessory instrument set. Set also includes a package of 8 mm Guide Wires (.15 cm x 38 cm), and Sterilization Tray....
The Small Oval Cannula System is designed to be the smallest oval cannula system currently available, and is utilized with the Caspari Suture Punch System. Disposable seals are available with this sy...
...
Suture retriever forceps...
Medicine Products: